GYRE icon

Gyre Therapeutics

46 hedge funds and large institutions have $51.4M invested in Gyre Therapeutics in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

10% more funds holding

Funds holding: 4246 (+4)

0.11% more ownership

Funds ownership: 8.26%8.36% (+0.11%)

33% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 18

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$117K
Puts
$78K
Net Calls
Net Calls Change

Top Buyers

1 +$2.09M
2 +$855K
3 +$850K
4
CS
Credit Suisse
Switzerland
+$688K
5
Citadel Advisors
Citadel Advisors
Florida
+$540K

Top Sellers

1 -$2.27M
2 -$1.13M
3 -$994K
4
FM
Fondren Management
Texas
-$336K
5
Morgan Stanley
Morgan Stanley
New York
-$277K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.3M
2
$5.01M
3
$4.97M
4
$4.88M
5
$4.65M
6
$4.11M
7
$2.67M
8
$2.56M
9
$2.09M
10
$1.85M
11
$1.55M
12
$1.39M
13
$945K
14
$855K
15
$725K
16
$705K
17
$688K
18
$535K
19
$456K
20
$422K
21
$334K
22
$314K
23
$290K
24
$272K
25
$241K